A paper outlining the management recommendations for the treatment of renal cell carcinoma has been published.
Get the full story...
A Brisbane oncologist says thousands more women will soon be able to afford an expensive medication that can help prevent the return of breast cancer.
Get the full story...
In a survey of 401 oncology registrars, 102 scored above the threshold for possible psychiatric morbidity and more than one in ten showed clinically important levels of depression. The main reasons cited include being over-stretched, keeping up-to-date with knowledge, fear of making mistakes, talking with distressed relatives, and poor senior support and team relations.
Get the full story...
Statistics show lung cancer is the leading cause of cancer death in African-Americans, with 21,550 new cases expected to be diagnosed and 16,700 deaths expected this year. Equally devastating, lung cancer is the leading cause of cancer death in Hispanic men and the second leading cause of cancer death in Hispanic women.
Get the full story...
Decreasing the rates of prostate cancer among black men may require improving access to routine health care, rather than increased education about the disease, a study from the University of North Carolina at Chapel Hill School of Medicine suggests.
Read the full story
More Convenient Access to Imaging Exams Can Improve Care, Boost Clinician and Staff Productivity
Read the full story
Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online.
Read the full story
Aggressive research currently underway brings hope of dramatic advances in breast cancer management, according to a new review. Published in the March 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society,
Read the full story
Genetic fingerprints that reveal where a brain cell came from remain distinct even after the cell becomes a brain tumor, an international coalition of scientists will report in the February 1 issue of Cancer Research
Read the full story
An international team of cancer specialists and imaging experts has developed standardized guidelines for assessing lymphoma response to treatment. The guidelines will provide clinicians worldwide with uniform criteria to compare and interpret clinical trials of lymphoma treatments and should facilitate the development of new therapies.
Read the full story
Preliminary findings show adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer live longer, according to a study presented today at the plenary session of the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.
Read the full story
Treatment with Aromasin after five years of tamoxifen results in significant improvement in relapse-free survival
Read the full story